One Health Publications

XIII Meeting of the Paul Ehrlich Euro-PhD Network & Cost Action – One Health approach to tackle neglected infectious diseases challenges: June 17 – 19, 2024, Rome, Italy

April 13, 2024

COST (European Cooperation in Science and Technology)



The Organizing Committee cordially invites you to participate at MedChem 2024 (XIII Meeting of the Paul Ehrlich Euro-PhD Network) to be held in Rome from the 17th to the 19th of June 2024 in conjunction with COST Action Workshop One Health approach to tackle neglected infectious diseases challenges.
As part of the COST Action workshop Young Researchers and Innovators will be engaged in the presentation of their research work in the field of neglected infectious diseases: Trypanosomiasis, Leishmaniosis, Schistosomiasis, Malaria and others in the field of medicinal chemistry/green chemistry and ecotoxicology. Designing lower environmental impact drugs.

The MedChem2024 will be hosted by the Department of Chemistry and Technologies of Drugs, Sapienza University of Rome (Building CU019).


The venue for the meeting will be the room ‘La Ginestra’ in the Stanislao Cannizzaro Building (CU014) and the room “Raffaele Giuliano in the Chemistry and Technologies of Drugs Building, both located in the Sapienza Campus. The MedChem2024 is organized over three days, each one opened with a Plenary Lecture.


All  kinds of communications in the area of Medicinal Chemistry can be submitted. One section will be dedicated to the COST Action OneHealthdrugs Workshop: “One Health approach to tackle neglected infectious diseases challenges.” (One Health Drugs). During the workshop young Researchers and Innovators will be engaged in the presentation of their research work in the field of neglected infectious diseases: Trypanosomiasis, Leishmaniosis, Schistosomiasis, Malaria and others in the field of medicinal chemistry/green chemistry and ecotoxicology. Designing lower environmental impact drugs.


The Introduction lecture will be held by prof. ROHINI R. ROOPNARINE


Oral communications (15 minutes) and poster sessions are scheduled every day. The poster session will have two parts: a Flash Presentation of a 2 minutes short version of the poster in front of all the delegates in the Conference Room followed by a classical Poster session during the coffee breaks. There is availability for 34 posters.


Wednesday morning session will include the presentations of the awardees of the Paul Ehrlich MedChem Euro-PhD Certificate and awards ceremony.


A social dinner will been organized for the night of Tuesday 18th.


The number of participants is limited to 170.

Save the dates in your calendar, Rome is waiting for you!

Paul Ehrlich Euro-PhD Network & OneHealthdrugs COST Action - IN PRESENCE MEETING
Department of Chemistry and Technology of Drugs La Sapienza University of Rome – 17-19 June 2024 Rome, ITALY

Paul Ehrlich Euro-PhD Network & OneHealthdrugs COST Action – IN PRESENCE MEETING

Also please see … OHD website in the announcement section: and the OneHealthdrugs website:

View Publication

April 12, 2024

Opinion  Open access  Published: 12 April 2024



Despite the increasing focus on strengthening One Health capacity building on global level, challenges remain in devising and implementing real-world interventions particularly in the Asia-Pacific region. Recognizing these gaps, the One Health Action Commission (OHAC) was established as an academic community for One Health action with an emphasis on research agenda setting to identify actions for highest impact.


Main text

This viewpoint describes the agenda of, and motivation for, the recently formed OHAC. Recognizing the urgent need for evidence to support the formulation of necessary action plans, OHAC advocates the adoption of both bottom-up and top-down approaches to identify the current gaps in combating zoonoses, antimicrobial resistance, addressing food safety, and to enhance capacity building for context-sensitive One Health implementation.



By promoting broader engagement and connection of multidisciplinary stakeholders, OHAC envisions a collaborative global platform for the generation of innovative One Health knowledge, distilled practical experience and actionable policy advice, guided by strong ethical principles of One Health. 

View Publication

Avian flu’s leap to humans: Understanding risks and prevention strategies (

April 11, 2024

“… Mitigation measures

Risk mitigation measures included in the One Health approach suggested surveillance among target animal and human populations along with the generation and sharing of genomic data. Target animals included wild and captive birds, poultry, susceptible domestic mammals such as fur animals, cats, pigs, and peri-domestic and peri-urban mammals.

The measures also comprised development and access to sustainable, rapid diagnostic methods using genomic data to screen for avian influenza virus in relevant populations. An additional critical area for risk mitigation was occupational safety in areas where humans interact closely with target animals. Furthermore, reassortment risk can be reduced by vaccinating individuals with a higher probability of occupational exposure to avian influenza against the seasonal influenza virus.

The scientific report also discussed other areas, such as improving the veterinary infrastructure, biosecurity, communicating the risk to various audiences, and vaccinating animals, which could help mitigate the risk of the avian influenza virus adapting to humans and animals. …”

View Publication

Bird Flu infects cows, chickens, but risk of spillover to humans is low : Shots – Health News : NPR

April 4, 2024

“… “We are in fairly unprecedented, uncharted territory, globally in relationship to avian influenza,” says Dr. Peter Rabinowitz, director of the UW Center for One Health Research.

But federal officials and scientists stress the risk to the public still remains low. …”

View Publication

Advancing Environmental Safety: Celebrating 20 years of Nanotechnology Research at EPA | US EPA

April 4, 2024

“One Health Strategy

EPA promotes a “One Health” strategy, a holistic approach with the goal of achieving optimum health outcomes across the shared environment of people, plants, and animals. Over the last 20 years, EPA has supported the One Health approach through many different efforts including environmental research on metal and carbon engineered nanomaterials (ENMs), nanopesticides, 3-D printer emissions, nanoplastics, quantum dots (semiconductor nanocrystals), and epoxy-based nanomaterials. EPA research looks at where these materials go and what happens to them along the way, also referred to as fate and transport. EPA research on how people and the environment are exposed to nanomaterials, as well as their toxicity, has resulted in more than 500 peer reviewed publications. This research has advanced our understanding of nanomaterials in the environment, fully embracing the “One Environment” component of One Health as recommended in the 2023 National Academies of Sciences, Engineering, and Medicine Report.”

View Publication

Avian influenza: One Health surveillance is key to prevent virus evolving | EFSA (

April 3, 2024

Risk reduction

Authorities from different fields should work together with a One Health perspective to limit the exposure of mammals, including humans, to AI viruses. Animal and human surveillance should be enhanced, together with genomic analysis and sharing of sequence data. At farms, biosecurity should be strengthened to prevent animals coming into contact with the infection and spreading it.”

View Publication

Makerere University takes lead in fight against zoonotic diseases (

April 1, 2024

Promotes ‘One Health’ approach to engage frontline communities

“Kampala, Uganda | RONALD MUSOKE  | Uganda has embraced the ‘One Health’ approach in order to be able to predict, prepare and effectively respond to public health challenges.


Clovice Kankya, an Associate Professor at Makerere University says the “One Health approach” entails collaboration of multiple disciplines working locally, nationally, and globally, to attain optional health for people, animals, and the environment. …I know that human beings often take precedence in whatever programmes we come up with but we need to really advocate for the role the environment plays in the One Health approach because if we don’t prevent, we are bound to get more of what we are experiencing right now.”

View Publication

UTMB One Health Newsletter – Issue 26, April 2024

April 1, 2024

Save the Dates: April 21 – 23, 2024

Our international Symposium Planning Committee of 22 diverse experts have designed a program which engages leaders in agricultural industry, public health, veterinary health, food safety, and environmental health institutions in this One Health oriented symposium. The symposium will be unique in that food productions experts will be centrally featured with the goal of identifying common ground from which new interdisciplinary research partnerships might arise and lead to better food resilience. We will also feature a poster competition with monetary awards.

For more information, please visit:

Contact for registration information.

View Publication

Dr. Samira Mubareka named Applied Public Health Chair – Sunnybrook Research Institute

March 29, 2024

Dr. Samira Mubareka, infectious disease physician, medical microbiologist and scientist at Sunnybrook, has received an Applied Public Health Chair, co-funded by the Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada (PHAC). …”


“… The focus of Dr. Mubareka’s Chair is to use a One Health approach that examines the interconnections between humans, animals and their environment in order to develop adaptive and innovative approaches to prevent zoonotic pathogen spillover between species. This builds on collaborative research with wildlife disease ecologists, computational biologists, epidemiologists, virologists, and many other colleagues in human and animal health.


The honour highlights Dr. Mubareka’s ongoing leadership in One Health, pandemic response, and surveillance of viral zoonoses like SARS-CoV-2. In the past few years, she has chaired the Royal Society of Canada’s COVID-19 Task Force’s One Health Working Group, and collaboratively co-founded a multidisciplinary research collective, the Wildlife Emerging Pathogen Initiative (Wild EPI). In the early days of the COVID-19 pandemic, Dr. Mubareka and colleagues isolated the SARS-CoV-2 virus in a Level 3 containment facility, which helped researchers in Canada develop better diagnostic testing, treatments and vaccines and gain a better understanding of SARS-CoV-2 biology. Dr. Mubareka will continue working with the Royal Society of Canada and other key partners on knowledge mobilization around One Health.  …”

View Publication

Infectious Disease Expert, Dr. Jonna Mazet Talks Emerging Health Threats at Sonenshine Lecture | Old Dominion University (

March 28, 2024

“… Dr. Mazet’s spoke to ODU students and faculty at her first lecture. The topic of her talk was on “Using One Health to Rank the Risk of Spillovers & Pandemic Potential for Novel Viruses.” Her talk centered around utilizing a One Health approach to emerging health threats including newly appeared or previously viral diseases that are increasing in incidence. She gave examples of various activities that occurred during the COVID-19 global pandemic but concluded with the observation that we have changed nothing to prevent or address things that could be applied to the next pandemic. Students and faculty asked questions at the completion of her talk and Dr. Mazet carefully and thoughtfully answered each and every question posed. Throughout the course of her visit on campus, Dr. Mazet also met with many graduate students. “She provided some excellent mentoring during her talks with the many graduate students interested in One Health in the Department,” said Holly Gaff, chair of ODU’s Department of Biological Sciences. …”

View Publication

Where should “Humans” be in “One Health”? Lessons from COVID-19 for One Health | Globalization and Health | Full Text (

March 26, 2024


The culling of animals that are infected, or suspected to be infected, with COVID-19 has fuelled outcry. What might have contributed to the ongoing debates and discussions about animal rights protection amid global health crises is the lack of a unified understanding and internationally agreed-upon definition of “One Health”. The term One Health is often utilised to describe the imperative to protect the health of humans, animals, and plants, along with the overarching ecosystem in an increasingly connected and globalized world. However, to date, there is a dearth of research on how to balance public health decisions that could impact all key stakeholders under the umbrella of One Health, particularly in contexts where human suffering has been immense. To shed light on the issue, this paper discusses whether One Health means “human-centred connected health” in a largely human-dominated planet, particularly amid crises like COVID-19. The insights of this study could help policymakers make more informed decisions that could effectively and efficiently protect human health while balancing the health and well-being of the rest of the inhabitants of our shared planet Earth.

View Publication

The Pandemic Agreement Draft: Will It Fully Embrace One Health? – Impakter

March 25, 2024

Animal health, biodiversity, ecological, environmental and plant health are key to addressing existing and future infectious disease risks

View Publication